BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9184608)

  • 1. IgA and IgG2 deficiency associated with zonisamide therapy: a case report.
    Maeoka Y; Hara T; Dejima S; Takeshita K
    Epilepsia; 1997 May; 38(5):611-3. PubMed ID: 9184608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of zonisamide on serum immunoglobulins.
    Fujimoto Y; Ikoma R; Shimizu T; Shimizu A
    Arzneimittelforschung; 1990 Aug; 40(8):855-8. PubMed ID: 2242076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency.
    Kutukculer N; Karaca NE; Demircioglu O; Aksu G
    Pediatr Allergy Immunol; 2007 Mar; 18(2):167-73. PubMed ID: 17338791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment.
    Kato Z; Watanabe M; Kondo N
    Eur J Pediatr; 2003 Mar; 162(3):209-211. PubMed ID: 12655433
    [No Abstract]   [Full Text] [Related]  

  • 5. IgG subclasses in symptomatic IgA deficiency.
    Tezcan I; Ersoy F; Sanal O
    Turk J Pediatr; 1992; 34(1):1-4. PubMed ID: 1509524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin A deficiency following treatment with lamotrigine.
    Maruyama S; Okamoto Y; Toyoshima M; Hanaya R; Kawano Y
    Brain Dev; 2016 Nov; 38(10):947-949. PubMed ID: 27396372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular acidosis associated with zonisamide therapy.
    Inoue T; Kira R; Kaku Y; Ikeda K; Gondo K; Hara T
    Epilepsia; 2000 Dec; 41(12):1642-4. PubMed ID: 11114225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.
    Kondo T; Kaneko S; Amano Y; Egawa I
    Epilepsia; 1996 Dec; 37(12):1242-4. PubMed ID: 8956859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin-induced IgG2 and IgG4 deficiencies in a patient with epilepsy.
    Ishizaka A; Nakanishi M; Kasahara E; Mizutani K; Sakiyama Y; Matsumoto S
    Acta Paediatr; 1992 Aug; 81(8):646-8. PubMed ID: 1392396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IgG subclass deficiency in childhood. Changes in the antigen specific immune response and significance of low IgG4 level].
    Bartmann P; Fleischer S; Wagner H; Kleihauer E
    Monatsschr Kinderheilkd; 1988 Jan; 136(1):31-7. PubMed ID: 2451127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclass deficiency in children with recurrent bronchitis.
    DeBaets F; Kint J; Pauwels R; Leroy J
    Eur J Pediatr; 1992 Apr; 151(4):274-8. PubMed ID: 1499580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide-induced behavior disorder in two children.
    Kimura S
    Epilepsia; 1994; 35(2):403-5. PubMed ID: 8156965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA and/or IgG subclass deficiency in children with recurrent respiratory infections and its relationship with chronic pulmonary damage.
    Ozkan H; Atlihan F; Genel F; Targan S; Gunvar T
    J Investig Allergol Clin Immunol; 2005; 15(1):69-74. PubMed ID: 15864886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term response to zonisamide in patients with West syndrome.
    Suzuki Y; Imai K; Toribe Y; Ueda H; Yanagihara K; Shimono K; Okinaga T; Ono J; Nagai T; Matsuoka T; Tagawa T; Abe J; Morita Y; Fujikawa Y; Arai H; Mano T; Okada S
    Neurology; 2002 May; 58(10):1556-9. PubMed ID: 12034801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgG subclass levels in patients with primary immunodeficiency syndromes or abnormal susceptibility to infections.
    Aucouturier P; Lacombe C; Bremard C; Lebranchu Y; Seligmann M; Griscelli C; Preud'Homme JL
    Clin Immunol Immunopathol; 1989 Apr; 51(1):22-37. PubMed ID: 2924438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of immunoglobulin subclasses and specific antibody determinations in the evaluation of recurrent infection in children.
    Gross S; Blaiss MS; Herrod HG
    J Pediatr; 1992 Oct; 121(4):516-22. PubMed ID: 1403382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage of IgA deficiency to Gm allotypes; the influence of Gm allotypes on IgA-IgG subclass deficiency.
    Oxelius VA; Carlsson AM; Hammarström L; Björkander J; Hanson LA
    Clin Exp Immunol; 1995 Feb; 99(2):211-5. PubMed ID: 7851013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of zonisamide: results of a multicenter study.
    Leppik IE; Willmore LJ; Homan RW; Fromm G; Oommen KJ; Penry JK; Sackellares JC; Smith DB; Lesser RP; Wallace JD
    Epilepsy Res; 1993 Feb; 14(2):165-73. PubMed ID: 8453952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study.
    Ranua J; Luoma K; Auvinen A; Peltola J; Haapala AM; Raitanen J; Isojärvi J
    Epilepsy Behav; 2005 Mar; 6(2):191-5. PubMed ID: 15710303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgG subclasses in patients with symptomatic IgA deficiency].
    de Gracia J; Miravitlles M; Vendrell M; Ròdrigo MJ; Codina R; Morell F
    Med Clin (Barc); 1995 May; 104(19):728-31. PubMed ID: 7791406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.